<DOC>
	<DOCNO>NCT00587210</DOCNO>
	<brief_summary>The purpose study ass exam quality accuracy MR use new oral contrast agent evaluation Crohn Disease small bowel .</brief_summary>
	<brief_title>Evaluation New Oral Contrast Agent MR Enterography Assessment Crohn Disease Small Bowel</brief_title>
	<detailed_description>Crohn Disease inflammatory condition involve small bowel . Patients usually undergo multiple image exams diagnosis surveillance disease . CT show excellent result detect active inflammation . In United States MR lag behind CT utilization image small bowel . An advantage MR CT lack radiation exposure patient . A new oral contrast agent available provide good distension small bowel allow improve identification active inflammation . The purpose study compare accuracy MR CT use new oral contrast agent ass exam quality .</detailed_description>
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Known suspected Crohn Disease Undergoing colonoscopy CT enterography Contraindication MR</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Crohn Disease</keyword>
	<keyword>Inflammatory Bowel Disease</keyword>
</DOC>